breaking

**Trump's Return to the White House: GOP Plans to Drastically Cut Medicaid** President Joe Biden saw record Medicaid enrollment and a historic low in the uninsured rate. But now, with Donald Trump's resurgence on the...

**Is Kennedy Looking to Add Alcohol to the List of Health Risks?** Robert F. Kennedy Jr. and his allies in the "Make America Healthy Again" movement have been vocal about various health concerns plaguing the...

Abe Sutton Tapped to Lead Medicare and Medicaid Innovation Center In a surprising turn of events, former Trump administration health policy aide Abe Sutton is poised to take the reins at the Center for...

AI in Healthcare: Ensuring Patient Safety Amidst Technological Advancements In a world where cutting-edge technology is revolutionizing every aspect of our lives, the healthcare industry is no exception. Artificial Intelligence (AI) has become a game-changer...

Breaking News: Cytokinetics CEO Firm on Company Growth Amid Drug Approval In a recent interview, Cytokinetics CEO Robert Blum made it abundantly clear that despite rumors of a potential acquisition, the company is focused solely...

Increasing Primary Care Physicians in Medical Schools: Key Strategies Medical schools across the nation are facing a critical challenge: the shortage of primary care doctors. The journey from medical student to specialist often leads students...

J&J Acquires Intra-Cellular Therapies for $14.6B, Expanding Mental Health Drug Portfolio In a groundbreaking move that has sent shockwaves through the pharmaceutical industry, Johnson & Johnson announced on Monday that it would be acquiring Intra-Cellular...

Latest Health Tech Deals Revealed Before JPM Conference In an exciting development for the health tech industry, the Food and Drug Administration (FDA) recently released new draft guidance aimed at developers of medical devices that...

DOJ Investigates Former UnitedHealth Group Doctors: Interviews Requested The Justice Department is delving into the practices of former UnitedHealth Group physicians, seeking insights into their experiences while working at practices under the health care giant's...

**New Biotech Firm Raises $300 Million with Focus on Heart Disease** In a bold move that has sent shockwaves through the biotech industry, MyoKardia's former CEO, Tassos Gianakakos, has announced the launch of a new...